Zentek (CVE:ZEN) Shares Up 6% – Still a Buy?

Zentek Ltd. (CVE:ZENGet Free Report)’s stock price shot up 6% during mid-day trading on Tuesday . The stock traded as high as C$0.79 and last traded at C$0.71. 528,136 shares were traded during trading, an increase of 239% from the average daily volume of 155,682 shares. The stock had previously closed at C$0.67.

Zentek Stock Performance

The company has a quick ratio of 7.59, a current ratio of 0.64 and a debt-to-equity ratio of 19.52. The company has a market capitalization of C$92.43 million, a PE ratio of -8.11 and a beta of 0.69. The company has a 50-day moving average price of C$0.76 and a two-hundred day moving average price of C$0.85.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Featured Stories

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.